Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.08 Billion CNY | -16.36% |
| 2022 | 1.16 Billion CNY | -10.76% |
| 2021 | 1.3 Billion CNY | 21.46% |
| 2020 | 1.07 Billion CNY | 5.29% |
| 2019 | 1.01 Billion CNY | 4.06% |
| 2018 | 978.84 Million CNY | 13.29% |
| 2017 | 864 Million CNY | 1.79% |
| 2016 | 848.81 Million CNY | -7.06% |
| 2015 | 913.32 Million CNY | 14.27% |
| 2014 | 799.27 Million CNY | 43.17% |
| 2013 | 558.25 Million CNY | 436.67% |
| 2012 | 104.02 Million CNY | 5.56% |
| 2011 | 98.54 Million CNY | 25.14% |
| 2010 | 78.74 Million CNY | 74.38% |
| 2009 | 45.15 Million CNY | 17.93% |
| 2008 | 38.28 Million CNY | 11.32% |
| 2007 | 34.39 Million CNY | 30.83% |
| 2006 | 26.28 Million CNY | 6.93% |
| 2005 | 24.58 Million CNY | -37.76% |
| 2004 | 39.5 Million CNY | 116.29% |
| 2003 | 18.26 Million CNY | -46.87% |
| 2002 | 34.37 Million CNY | -13.84% |
| 2001 | 39.89 Million CNY | 82.46% |
| 2000 | 21.86 Million CNY | -21.64% |
| 1999 | 27.9 Million CNY | -5.79% |
| 1998 | 29.62 Million CNY | -31.25% |
| 1997 | 43.08 Million CNY | 40.67% |
| 1996 | 30.63 Million CNY | 16.04% |
| 1995 | 26.39 Million CNY | -87.13% |
| 1994 | 205.13 Million CNY | 731.87% |
| 1993 | 24.65 Million CNY | 66.31% |
| 1992 | 14.82 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 215.95 Million CNY | -9.99% |
| 2024 Q3 | 204.01 Million CNY | -2.07% |
| 2024 Q1 | 239.92 Million CNY | -12.24% |
| 2023 Q3 | 216.29 Million CNY | -26.63% |
| 2023 Q1 | 276.58 Million CNY | -10.11% |
| 2023 Q2 | 294.79 Million CNY | 6.58% |
| 2023 FY | 972.3 Million CNY | -16.36% |
| 2023 Q4 | 273.4 Million CNY | 26.4% |
| 2022 Q4 | 307.7 Million CNY | 15.63% |
| 2022 Q2 | 299.73 Million CNY | 3.75% |
| 2022 Q3 | 266.11 Million CNY | -11.21% |
| 2022 FY | 1.16 Billion CNY | -10.76% |
| 2022 Q1 | 288.88 Million CNY | -22.57% |
| 2021 Q2 | 319.36 Million CNY | 11.78% |
| 2021 Q1 | 285.7 Million CNY | -20.22% |
| 2021 FY | 1.3 Billion CNY | 21.46% |
| 2021 Q3 | 324.44 Million CNY | 1.59% |
| 2021 Q4 | 373.09 Million CNY | 14.99% |
| 2020 Q1 | 147.31 Million CNY | -47.27% |
| 2020 Q2 | 260.62 Million CNY | 76.92% |
| 2020 Q3 | 306.37 Million CNY | 17.55% |
| 2020 Q4 | 358.12 Million CNY | 16.89% |
| 2020 FY | 1.07 Billion CNY | 5.29% |
| 2019 FY | 1.01 Billion CNY | 4.06% |
| 2019 Q4 | 279.37 Million CNY | 3.86% |
| 2019 Q3 | 268.99 Million CNY | 3.86% |
| 2019 Q2 | 258.98 Million CNY | 22.62% |
| 2019 Q1 | 211.21 Million CNY | -38.14% |
| 2018 Q3 | 236.96 Million CNY | -6.48% |
| 2018 Q4 | 341.44 Million CNY | 44.09% |
| 2018 FY | 978.84 Million CNY | 13.29% |
| 2018 Q1 | 147.05 Million CNY | -49.73% |
| 2018 Q2 | 253.38 Million CNY | 72.3% |
| 2017 Q2 | 200.24 Million CNY | 45.62% |
| 2017 Q3 | 233.68 Million CNY | 16.7% |
| 2017 Q4 | 292.55 Million CNY | 25.2% |
| 2017 FY | 864 Million CNY | 1.79% |
| 2017 Q1 | 137.51 Million CNY | -57.21% |
| 2016 Q3 | 193.97 Million CNY | -10.93% |
| 2016 Q2 | 217.78 Million CNY | 88.21% |
| 2016 FY | 848.81 Million CNY | -7.06% |
| 2016 Q4 | 321.33 Million CNY | 65.66% |
| 2016 Q1 | 115.71 Million CNY | -65.27% |
| 2015 Q2 | 202.12 Million CNY | 18.33% |
| 2015 Q1 | 170.82 Million CNY | -35.24% |
| 2015 FY | 913.32 Million CNY | 14.27% |
| 2015 Q4 | 333.15 Million CNY | 60.78% |
| 2015 Q3 | 207.21 Million CNY | 2.52% |
| 2014 Q4 | 263.76 Million CNY | 29.91% |
| 2014 FY | 799.27 Million CNY | 43.17% |
| 2014 Q2 | 175.08 Million CNY | 11.26% |
| 2014 Q1 | 157.37 Million CNY | -30.92% |
| 2014 Q3 | 203.04 Million CNY | 15.97% |
| 2013 Q3 | 189.36 Million CNY | 48.48% |
| 2013 FY | 558.25 Million CNY | 436.67% |
| 2013 Q4 | 227.81 Million CNY | 20.31% |
| 2013 Q1 | 13.54 Million CNY | -67.25% |
| 2013 Q2 | 127.53 Million CNY | 841.55% |
| 2012 Q2 | 24.95 Million CNY | 96.05% |
| 2012 Q3 | 24.97 Million CNY | 0.08% |
| 2012 Q4 | 41.35 Million CNY | 65.59% |
| 2012 FY | 104.02 Million CNY | 5.56% |
| 2012 Q1 | 12.73 Million CNY | -61.78% |
| 2011 FY | 98.54 Million CNY | 25.14% |
| 2011 Q4 | 33.3 Million CNY | 15.92% |
| 2011 Q3 | 28.73 Million CNY | 18.51% |
| 2011 Q2 | 24.24 Million CNY | 97.78% |
| 2011 Q1 | 12.25 Million CNY | -62.62% |
| 2010 Q3 | 22.51 Million CNY | 20.64% |
| 2010 Q1 | 4.77 Million CNY | -77.4% |
| 2010 Q2 | 18.66 Million CNY | 291.06% |
| 2010 FY | 78.74 Million CNY | 74.38% |
| 2010 Q4 | 32.79 Million CNY | 45.65% |
| 2009 Q2 | 9.82 Million CNY | 165.2% |
| 2009 FY | 45.15 Million CNY | 17.93% |
| 2009 Q4 | 21.11 Million CNY | 100.75% |
| 2009 Q3 | 10.51 Million CNY | 7.06% |
| 2009 Q1 | 3.7 Million CNY | -74.72% |
| 2008 Q3 | 12.44 Million CNY | 65.48% |
| 2008 FY | 38.28 Million CNY | 11.32% |
| 2008 Q1 | 3.67 Million CNY | 4.23% |
| 2008 Q2 | 7.51 Million CNY | 104.56% |
| 2008 Q4 | 14.65 Million CNY | 17.79% |
| 2007 Q1 | 3.26 Million CNY | -37.65% |
| 2007 Q4 | 3.52 Million CNY | -76.87% |
| 2007 Q3 | 15.24 Million CNY | 23.37% |
| 2007 Q2 | 12.35 Million CNY | 278.73% |
| 2007 FY | 34.39 Million CNY | 30.83% |
| 2006 Q2 | 6.42 Million CNY | 131.48% |
| 2006 Q3 | 11.85 Million CNY | 84.35% |
| 2006 Q4 | 5.23 Million CNY | -55.84% |
| 2006 FY | 26.28 Million CNY | 6.93% |
| 2006 Q1 | 2.77 Million CNY | -35.04% |
| 2005 Q4 | 4.27 Million CNY | -25.8% |
| 2005 Q1 | 5.78 Million CNY | -65.32% |
| 2005 Q2 | 8.76 Million CNY | 51.48% |
| 2005 Q3 | 5.76 Million CNY | -34.26% |
| 2005 FY | 24.58 Million CNY | -37.76% |
| 2004 FY | 39.5 Million CNY | 116.29% |
| 2004 Q1 | 7.51 Million CNY | -16.66% |
| 2004 Q2 | 9.7 Million CNY | 29.24% |
| 2004 Q3 | 5.59 Million CNY | -42.36% |
| 2004 Q4 | 16.68 Million CNY | 198.07% |
| 2003 Q2 | 3.35 Million CNY | -5.19% |
| 2003 Q4 | 9.01 Million CNY | 284.33% |
| 2003 Q1 | 3.54 Million CNY | -84.4% |
| 2003 Q3 | 2.34 Million CNY | -30.18% |
| 2003 FY | 18.26 Million CNY | -46.87% |
| 2002 Q3 | 4.52 Million CNY | 26.42% |
| 2002 FY | 34.37 Million CNY | -13.84% |
| 2002 Q1 | 3.56 Million CNY | 0.0% |
| 2002 Q2 | 3.57 Million CNY | 0.23% |
| 2002 Q4 | 22.71 Million CNY | 402.27% |
| 2001 FY | 39.89 Million CNY | 82.46% |
| 2000 FY | 21.86 Million CNY | -21.64% |
| 1999 FY | 27.9 Million CNY | -5.79% |
| 1998 FY | 29.62 Million CNY | -31.25% |
| 1997 FY | 43.08 Million CNY | 40.67% |
| 1996 FY | 30.63 Million CNY | 16.04% |
| 1995 FY | 26.39 Million CNY | -87.13% |
| 1994 FY | 205.13 Million CNY | 731.87% |
| 1993 FY | 24.65 Million CNY | 66.31% |
| 1992 FY | 14.82 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 14.38 Billion CNY | 92.45% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.3 Billion CNY | 17.068% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.14 Billion CNY | 65.511% |
| Aurora Optoelectronics Co.,Ltd. | 482.31 Million CNY | -125.171% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 64.1 Million CNY | -1594.254% |
| NanJing Pharmaceutical Company Limited | 2.3 Billion CNY | 52.901% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 818.48 Million CNY | -32.69% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.08 Billion CNY | 0.297% |